BMJ Has Discovered That 40% Of America Women Have Dense Breast
Contributor: Hybrid Media
Austin — ( Associated Press ) Hybrid Media is attending The 2018 Annual Clinical And Science Meeting (ACOG ). Women Its A MayDay And Time To Be Informed With The New Information On Breast Cancer. Women With Dense Breast Have To Go The Extra Mile After A Mammogram To Be Sure There Is No Breast Cancer. At Barrons Medical Journal ( BMJ ) We Have Discovered That 40% Of America Women Have Dense Breast.
“A new study by the University of Texas MD Anderson Cancer Center concluded that Tomosynthesis is highly accurate for detecting positive margins intra-operatively, compared to traditional 2-D imaging with extensive processing, in breast cancer patients undergoing segmental mastectomy. With statistics indicating that nationally, 20 to 30% of these patients need to undergo re-excision in order to obtain negative margins, there is a global need for a more accurate, rapid, and easy-to-use technology to enable improved patient outcomes. ”
This means after a Physicians has informed you your breast is Dense then its time for Tomosynthesis, also referred to as “3-Dimensional mammography” (3D mammography) or “tomo”, uses a dedicated electronic detector system to obtain multiple projection images which are “synthesized” by the computer to create thin slices of the breast.
Hybrid Media has discovered The InveniaTM ABUS (Automated Breast Ultrasound System) s a comfortable, non-ionizing alternative to other supplemental screening options for women with dense breast tissue. When used in addition to mammography, Invenia ABUS can improve breast cancer detection by 55 percent over mammography* alone
What is it? Mammograms are low-dose x-rays of the breast that have been used for screening since the 1980s.
How mammography works: The breast is briefly squeezed (compressed) in two different positions and x-rays of the breast are taken. The total examination takes about 10 minutes to complete. Sometimes additional images are needed to fully include all the breast tissue. The compression reduces the amount of radiation needed to penetrate the tissue and also spreads out the breast tissue to help produce excellent images. Compression also reduces motion which can blur the image and cause important findings to be missed. Cancers are seen as masses, areas of tissue asymmetry, calcifications, and/or areas of distortion. Many noncancerous conditions also produce masses and calcifications and normal tissue can appear as areas of asymmetry.
Benefits: 2-D mammograms allow detection of 2 to 7 cancers for every thousand women screened. A woman’s breast density is determined through her mammogram (rated on a four-level scale). Mammography is the recommended first step in breast cancer screening for all women aged 40 years and older except those who are pregnant. Some women at high risk may start mammographic screening by age 30. Screening mammography is the only technology that has been studied by multiple randomized controlled trials. Across those trials, mammography has been shown to reduce deaths due to breast cancer.
1. Breast density is determined through a woman’s mammogram and described as one of four categories depending on the amount of breast tissue in comparison to fat in the breast.
2. 40% of women age 40 and over have dense breasts.
3. Cancer is 4-6 times more likely in women with extremely dense breasts than in women with fatty breasts.
4. Though mammograms find some cancers not seen on other screening tests, in dense breasts, mammograms will miss more than 50% of the cancers present.
5. Other screening tests, such as ultrasound or breast MRI, in addition to mammography substantially increase detection of early stage breast cancers in dense breasts.
Supplemental screening by ultrasound is a contentious issue. That’s in part because among radiologists, not all agree that the sound-wave technology is the best way to check dense breasts for cancer, or that it’s economically feasible.
One possible solution to lower the costs and improve screening, both, is to automate the process. Over the long haul – after a hospital or radiology practice has invested in a machine and software to go with it, and training – automated ultrasound systems can render screening faster, reliable and more accurate.
GE Healthcare manufactures the only automated breast ultrasound screening (ABUS) system that’s received FDA approval for supplemental screening of women with dense breasts.
Comments
Post a Comment